Capralogics Inc.
Hardwick, MA Doing business as Capralogics Inc.
- UEI
- C1AJXN3ARJJ3
- CAGE
- 5MUR2
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 235 Czesky Rd, Gilbertville, MA 01031, USA
- Website
- capralogics.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Immunization of alpacas with HIV 1 ENV trimers to develop broadly neutralizing nanobodies targeting CD4 biding site | National Institute of Allergy and Infectious Diseases | $160,920 | |
| Testing services | National Cancer Institute | $16,265 | |
| Service for llama injections, maintenance and sample shipping. For COVID19 research | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $11,315 |
About Capralogics Inc.
Capralogics Inc. is a full service polyclonal antibody production facility that has been dedicated to providing high quality animal serum and PBMCs to the diagnostic, pharmaceutical and research industries for over 29 years. Capralogics Inc. is a for-profit corporate entity and manufacturer of goods registered in the System for Award Management to receive federal contracts and grants.
Capralogics Inc. has received several prime contract awards from the Department of Health and Human Services' National Institutes of Health (NIH) to conduct immunization studies and provide testing services. In August 2023, NIH's National Institute of Allergy and Infectious Diseases awarded Capralogics a $198,570 purchase order to immunize alpacas with HIV-1 envelope trimers, collect blood samples, isolate and store peripheral blood mononuclear cells, and ship samples to develop broadly neutralizing nanobodies targeting the virus' CD4 binding site. This non-competitive award continues previous studies begun in 2007. The National Cancer Institute also issued Capralogics a $16,265 firm-fixed-price purchase order in July 2023 for testing services supporting the agency's cancer research mission. In January 2021, during the COVID-19 pandemic, NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases contracted with Capralogics for $11,315 to provide llama injection, maintenance, and sample shipping services to aid coronavirus research efforts. No subcontractors or set-aside designations were identified across these prime contract awards to the for-profit manufacturer focused on animal-based antibody development and testing.
Quick answers
What is Capralogics Inc.'s UEI?
Capralogics Inc.'s Unique Entity ID (UEI) in SAM.gov is C1AJXN3ARJJ3.
What is Capralogics Inc.'s CAGE code?
Capralogics Inc.'s CAGE code is 5MUR2.
What is Capralogics Inc.'s primary NAICS code?
Capralogics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Capralogics Inc. located?
Capralogics Inc.'s physical address in SAM.gov is 235 Czesky Rd, Gilbertville, MA 01031, USA.
Is Capralogics Inc. registered in SAM.gov?
Yes. Capralogics Inc.'s SAM.gov registration is active through December 1, 2026.
What is Capralogics Inc.'s most recent federal award?
Capralogics Inc.'s most recent federal contract award is Immunization of alpacas with HIV 1 ENV trimers to develop broadly neutralizing nanobodies targeting CD4 biding site (75N93023P01111), from National Institute of Allergy and Infectious Diseases, on August 25, 2023.
On GovTribe
See Capralogics Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors